The epidemiology of endometrial and ovarian cancer
- PMID: 22244658
- PMCID: PMC3259524
- DOI: 10.1016/j.hoc.2011.10.009
The epidemiology of endometrial and ovarian cancer
Abstract
This review highlights similarities in the epidemiology of endometrial and ovarian cancer, including highly correlated incidence rates and similar risk factor profiles. Factors that decrease risk for both cancers include a late menarche, early age at first birth, giving birth and breastfeeding, and use of oral contraceptives. Short or irregular cycles and late menopause are associated with increased risk for both. Other risk factors that appear to operate in a similar direction include decreased risk associated with IUD use or a tubal ligation, and increased risk associated with obesity, lack of exercise, and use of talc powders in genital hygiene. Estrogen excess is proposed as the underlying mechanism for most endometrial cancers, whereas incessant ovulation has been suggested as the explanation for ovarian cancer. However, an increased number of estimated ovulatory cycles correlates directly with risk for both endometrial and ovarian cancer, suggesting that reproductive tissue turnover with an accumulation of PTEN or p53 mutations represents a possible common mechanism. An immune-based explanation involving mucin proteins represents another common mechanism that could explain additional risk factors. Maintenance of ideal weight, breastfeeding children, use of oral contraceptives, and avoidance of talc powders in genital hygiene are measures that could lower the risk for both types of cancer. Careful selection of patients for prophylactic oophorectomy for those women who are coming to hysterectomy for benign disease is an additional measure to consider for ovarian cancer.
Copyright © 2012 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.Contraception. 1992 Feb;45(2):93-104. doi: 10.1016/0010-7824(92)90043-s. Contraception. 1992. PMID: 1559340
-
The prevention of breast cancer through reduced ovarian steroid exposure.Acta Oncol. 1992;31(2):167-74. doi: 10.3109/02841869209088898. Acta Oncol. 1992. PMID: 1622631 Review.
-
Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer.Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):30-5. doi: 10.1158/1055-9965.EPI-06-0688. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17220329
-
Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico.Cancer Res. 1999 Aug 1;59(15):3658-62. Cancer Res. 1999. PMID: 10446978
-
Ovarian and endometrial cancers.Cancer Surv. 1994;19-20:287-307. Cancer Surv. 1994. PMID: 7895220 Review.
Cited by
-
Comparison of dynamic contrast-enhanced magnetic resonance imaging with T2-weighted imaging for preoperative staging of early endometrial carcinoma.Onco Targets Ther. 2015 Jul 17;8:1743-51. doi: 10.2147/OTT.S86519. eCollection 2015. Onco Targets Ther. 2015. PMID: 26229482 Free PMC article.
-
Long non-coding RNA taurine-upregulated gene 1 predicts unfavorable prognosis, promotes cells proliferation, and inhibits cells apoptosis in epithelial ovarian cancer.Medicine (Baltimore). 2018 May;97(19):e0575. doi: 10.1097/MD.0000000000010575. Medicine (Baltimore). 2018. PMID: 29742691 Free PMC article.
-
Identification of Metabolomic Biomarkers for Endometrial Cancer and Its Recurrence after Surgery in Postmenopausal Women.Front Endocrinol (Lausanne). 2018 Mar 12;9:87. doi: 10.3389/fendo.2018.00087. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29593653 Free PMC article.
-
MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer.Cancer Biol Med. 2015 Dec;12(4):328-41. doi: 10.7497/j.issn.2095-3941.2015.0024. Cancer Biol Med. 2015. PMID: 26779370 Free PMC article. Review.
-
Sociological Transition and Breast Cancer in the Arab World: the Experience of Lebanon.Asian Pac J Cancer Prev. 2017 May 1;18(5):1357-1364. doi: 10.22034/APJCP.2017.18.5.1357. Asian Pac J Cancer Prev. 2017. PMID: 28612586 Free PMC article.
References
-
- Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15(1):10–7. - PubMed
-
- Deligdisch L, Holinka CF. Endometrial carcinoma: two diseases? Cancer Detect Prev. 1987;10(3-4):237–46. - PubMed
-
- Scully R. Tumors of the ovary and maldeveloped gonads. Vol Second Series. Washington, DC: Armed Forces Institute of Pathology; 1979.
-
- Russell P. Surface epithelial-stromal tumors of the ovary. In: Kurman RJ, editor. Blaustein’s Pathology of the Female Genital Tract. 4. New York: Springer-Verlag; 1994. pp. 705–82.
-
- American Cancer Society. Cancer Facts and Figures 2008. 2008
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous